R. Bernard

The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers.

H. Eichler, F. Lordick, C. Peschel, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Blood component use and associated costs after standard dose chemotherapy—a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany

C. Peschel, W. Schramm, K. Berger, 2012, Supportive Care in Cancer.

The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care — an observational analysis on non-small-cell lung cancer patients

C. Peschel, K. Berger, M. Shlaen, 2013, Supportive Care in Cancer.

Management of Febrile Neutropenia – a German Prospective Hospital Cost Analysis in Lymphoproliferative Disorders, Non-Small Cell Lung Cancer, and Primary Breast Cancer

C. Peschel, V. Jacobs, K. Berger, 2011, Oncology Research and Treatment.

Comparison of Actual Hospital Costs versus DRG Revenues for In-Patient Treatment of Febrile Neutropenia during Adjuvant Anthracycline plus/minus Taxane-Based Chemotherapy for Primary Breast Cancer

N. Harbeck, V. Jacobs, M. Kiechle, 2011, Oncology Research and Treatment.

Cost Analysis Comparing an Anthracycline/Docetaxel Regimen to CMF in Patients with Early Stage Breast Cancer

N. Harbeck, W. Kuhn, V. Jacobs, 2009, Oncology Research and Treatment.

Health resource consumption and costs attributable to chemotherapy-induced toxicity in German routine hospital care in lymphoproliferative disorder and NSCLC patients.

C. Peschel, K. Berger, M. Shlaen, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Integrated IT Platform for Coordination of Diagnosis, Treatment, and Aftercare of Prosthetic Joint Infections

Christian Suren, Susanne Feihl, Christiane Querbach, 2019, In Vivo.